Privia Health Group, Inc. PRVA

FY2025 · ended Dec 31, 2025 · Revenue $2.12B, +22.3% YoY · Filed Feb 27, 2026

Privia Health Group, Inc. (PRVA) files with the SEC under industry code 8000, Services-Health Services. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $2.1 billion and net income of $22.9 million. As of Jun 30, 2026 it held $412.2 million in cash and investments and $8.7 million in total debt.

Revenue (TTM)
$2.36B
+24.1% vs year-ago TTM
Net income (TTM)
$28.12M
+89.5% vs year-ago TTM
Operating cash flow (TTM)
$131.13M
+42.7% vs year-ago TTM
Free cash flow
$80.67M
+71.3% vs prior year
EPS (TTM)
$0.22
+84.5% vs year-ago TTM
Dividend per share
None
Shares outstanding
123.69M
+2.6% vs prior year
Net cash
$403.47M
as of Jun 30, 2026
Operating margin
1.9%
FY 2026

Company profile

Industry
Services-Health Services (SIC 8000)
Listed as
PRVA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Arlington, VA
SEC filer status
Large accelerated filer
SEC CIK
1759655
Former names
PH Group Parent Corp. (until Mar 11, 2020)

Other Services-Health Services companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$2.1B
$1.7B
$1.7B
$1.4B
$966.2M
Operating income
$34.2M
$17.0M
$20.6M
-$19.1M
-$217.4M
Net income
$22.9M
$14.4M
$23.1M
-$8.6M
-$188.2M
Diluted EPS
$0.18
$0.11
$0.19
-$0.08
-$1.83
Operating cash flow
$163.4M
$109.3M
$80.8M
$47.2M
$55.1M
Free cash flow
—
—
$80.7M
$47.1M
$54.5M
Total assets
$1.4B
$1.1B
$999.9M
$792.8M
$686.4M
Total liabilities
$578.4M
$452.3M
$392.5M
$273.8M
$236.2M
Stockholders' equity
$737.2M
$635.2M
$561.4M
$499.1M
$426.9M
Cash and investments
$479.7M
$491.1M
$389.5M
$348.0M
$320.6M
Total debt
$9.5M
$5.6M
$8.3M
$11.5M
$14.1M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Officer or director change
Aug 18, 2026 Aug 12, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Officer or director change
Jul 7, 2026 Jul 6, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.